Size-Exclusion Chromatography Combined with Ultrafiltration Efficiently Isolates Extracellular Vesicles from Human Blood Samples in Health and Disease

There is still a need for an efficient method for the isolation of extracellular vesicles (EVs) from human blood that provides a reliable yield with acceptable purity. Blood is a source of circulating EVs, but soluble proteins and lipoproteins hamper their concentration, isolation, and detection. Th...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 24; no. 4; p. 3663
Main Authors Franco, Chiara, Ghirardello, Anna, Bertazza, Loris, Gasparotto, Michela, Zanatta, Elisabetta, Iaccarino, Luca, Valadi, Hadi, Doria, Andrea, Gatto, Mariele
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 11.02.2023
MDPI
Subjects
Autoimmune diseases
Biochemistry & Molecular Biology
Biomarkers
Blood
Cell culture
Chemistry
Chromatography
Chromatography, Gel - methods
Disease
Ethylenediaminetetraacetic acid
Extracellular vesicles
Extracellular Vesicles - chemistry
Flow cytometry
Humans
idiopathic inflammatory myopathies
Lipoproteins - metabolism
Membrane lipids
Microscopy, Electron, Transmission
Molecular Biology
Molekylärbiologi
Morphology
Nanoparticles
Plasma
polymyositis
Proteins
size-exclusion chromatography
ultrafiltration
Ultrafiltration - methods
idiopathic inflammatory myopathies
extracellular vesicles
ultrafiltration
size-exclusion chromatography
Online AccessGet full text
ISSN1422-0067
1661-6596
1422-0067
DOI10.3390/ijms24043663

Cover

Abstract There is still a need for an efficient method for the isolation of extracellular vesicles (EVs) from human blood that provides a reliable yield with acceptable purity. Blood is a source of circulating EVs, but soluble proteins and lipoproteins hamper their concentration, isolation, and detection. This study aims to investigate the efficiency of EV isolation and characterization methods not defined as “gold standard”. EVs were isolated from human platelet-free plasma (PFP) of patients and healthy donors through size-exclusion chromatography (SEC) combined with ultrafiltration (UF). Then, EVs were characterized using transmission electron microscopy (TEM), imaging flow cytometry (IFC), and nanoparticle tracking analysis (NTA). TEM images showed intact and roundish nanoparticles in pure samples. IFC analysis detected a prevalence of CD63+ EVs compared to CD9+, CD81+, and CD11c+ EVs. NTA confirmed the presence of small EVs with a concentration of ~1010 EVs/mL that were comparable when stratifying the subjects by baseline demographics; conversely, concentration differed according to the health status across healthy donors and patients affected with autoimmune diseases (130 subjects in total, with 65 healthy donors and 65 idiopathic inflammatory myopathy (IIM) patients). Altogether, our data show that a combined EV isolation method, i.e., SEC followed by UF, is a reliable approach to isolate intact EVs with a significant yield from complex fluids, which might characterize disease conditions early.
AbstractList There is still a need for an efficient method for the isolation of extracellular vesicles (EVs) from human blood that provides a reliable yield with acceptable purity. Blood is a source of circulating EVs, but soluble proteins and lipoproteins hamper their concentration, isolation, and detection. This study aims to investigate the efficiency of EV isolation and characterization methods not defined as "gold standard". EVs were isolated from human platelet-free plasma (PFP) of patients and healthy donors through size-exclusion chromatography (SEC) combined with ultrafiltration (UF). Then, EVs were characterized using transmission electron microscopy (TEM), imaging flow cytometry (IFC), and nanoparticle tracking analysis (NTA). TEM images showed intact and roundish nanoparticles in pure samples. IFC analysis detected a prevalence of CD63+ EVs compared to CD9+, CD81+, and CD11c+ EVs. NTA confirmed the presence of small EVs with a concentration of ~1010 EVs/mL that were comparable when stratifying the subjects by baseline demographics; conversely, concentration differed according to the health status across healthy donors and patients affected with autoimmune diseases (130 subjects in total, with 65 healthy donors and 65 idiopathic inflammatory myopathy (IIM) patients). Altogether, our data show that a combined EV isolation method, i.e., SEC followed by UF, is a reliable approach to isolate intact EVs with a significant yield from complex fluids, which might characterize disease conditions early.There is still a need for an efficient method for the isolation of extracellular vesicles (EVs) from human blood that provides a reliable yield with acceptable purity. Blood is a source of circulating EVs, but soluble proteins and lipoproteins hamper their concentration, isolation, and detection. This study aims to investigate the efficiency of EV isolation and characterization methods not defined as "gold standard". EVs were isolated from human platelet-free plasma (PFP) of patients and healthy donors through size-exclusion chromatography (SEC) combined with ultrafiltration (UF). Then, EVs were characterized using transmission electron microscopy (TEM), imaging flow cytometry (IFC), and nanoparticle tracking analysis (NTA). TEM images showed intact and roundish nanoparticles in pure samples. IFC analysis detected a prevalence of CD63+ EVs compared to CD9+, CD81+, and CD11c+ EVs. NTA confirmed the presence of small EVs with a concentration of ~1010 EVs/mL that were comparable when stratifying the subjects by baseline demographics; conversely, concentration differed according to the health status across healthy donors and patients affected with autoimmune diseases (130 subjects in total, with 65 healthy donors and 65 idiopathic inflammatory myopathy (IIM) patients). Altogether, our data show that a combined EV isolation method, i.e., SEC followed by UF, is a reliable approach to isolate intact EVs with a significant yield from complex fluids, which might characterize disease conditions early.
There is still a need for an efficient method for the isolation of extracellular vesicles (EVs) from human blood that provides a reliable yield with acceptable purity. Blood is a source of circulating EVs, but soluble proteins and lipoproteins hamper their concentration, isolation, and detection. This study aims to investigate the efficiency of EV isolation and characterization methods not defined as "gold standard". EVs were isolated from human platelet-free plasma (PFP) of patients and healthy donors through size-exclusion chromatography (SEC) combined with ultrafiltration (UF). Then, EVs were characterized using transmission electron microscopy (TEM), imaging flow cytometry (IFC), and nanoparticle tracking analysis (NTA). TEM images showed intact and roundish nanoparticles in pure samples. IFC analysis detected a prevalence of CD63+ EVs compared to CD9+, CD81+, and CD11c+ EVs. NTA confirmed the presence of small EVs with a concentration of ~10 EVs/mL that were comparable when stratifying the subjects by baseline demographics; conversely, concentration differed according to the health status across healthy donors and patients affected with autoimmune diseases (130 subjects in total, with 65 healthy donors and 65 idiopathic inflammatory myopathy (IIM) patients). Altogether, our data show that a combined EV isolation method, i.e., SEC followed by UF, is a reliable approach to isolate intact EVs with a significant yield from complex fluids, which might characterize disease conditions early.
There is still a need for an efficient method for the isolation of extracellular vesicles (EVs) from human blood that provides a reliable yield with acceptable purity. Blood is a source of circulating EVs, but soluble proteins and lipoproteins hamper their concentration, isolation, and detection. This study aims to investigate the efficiency of EV isolation and characterization methods not defined as "gold standard". EVs were isolated from human platelet-free plasma (PFP) of patients and healthy donors through size-exclusion chromatography (SEC) combined with ultrafiltration (UF). Then, EVs were characterized using transmission electron microscopy (TEM), imaging flow cytometry (IFC), and nanoparticle tracking analysis (NTA). TEM images showed intact and roundish nanoparticles in pure samples. IFC analysis detected a prevalence of CD63+ EVs compared to CD9+, CD81+, and CD11c+ EVs. NTA confirmed the presence of small EVs with a concentration of ~10[sup.10] EVs/mL that were comparable when stratifying the subjects by baseline demographics; conversely, concentration differed according to the health status across healthy donors and patients affected with autoimmune diseases (130 subjects in total, with 65 healthy donors and 65 idiopathic inflammatory myopathy (IIM) patients). Altogether, our data show that a combined EV isolation method, i.e., SEC followed by UF, is a reliable approach to isolate intact EVs with a significant yield from complex fluids, which might characterize disease conditions early.
There is still a need for an efficient method for the isolation of extracellular vesicles (EVs) from human blood that provides a reliable yield with acceptable purity. Blood is a source of circulating EVs, but soluble proteins and lipoproteins hamper their concentration, isolation, and detection. This study aims to investigate the efficiency of EV isolation and characterization methods not defined as “gold standard”. EVs were isolated from human platelet-free plasma (PFP) of patients and healthy donors through size-exclusion chromatography (SEC) combined with ultrafiltration (UF). Then, EVs were characterized using transmission electron microscopy (TEM), imaging flow cytometry (IFC), and nanoparticle tracking analysis (NTA). TEM images showed intact and roundish nanoparticles in pure samples. IFC analysis detected a prevalence of CD63+ EVs compared to CD9+, CD81+, and CD11c+ EVs. NTA confirmed the presence of small EVs with a concentration of ~1010 EVs/mL that were comparable when stratifying the subjects by baseline demographics; conversely, concentration differed according to the health status across healthy donors and patients affected with autoimmune diseases (130 subjects in total, with 65 healthy donors and 65 idiopathic inflammatory myopathy (IIM) patients). Altogether, our data show that a combined EV isolation method, i.e., SEC followed by UF, is a reliable approach to isolate intact EVs with a significant yield from complex fluids, which might characterize disease conditions early.
There is still a need for an efficient method for the isolation of extracellular vesicles (EVs) from human blood that provides a reliable yield with acceptable purity. Blood is a source of circulating EVs, but soluble proteins and lipoproteins hamper their concentration, isolation, and detection. This study aims to investigate the efficiency of EV isolation and characterization methods not defined as "gold standard". EVs were isolated from human platelet-free plasma (PFP) of patients and healthy donors through size-exclusion chromatography (SEC) combined with ultrafiltration (UF). Then, EVs were characterized using transmission electron microscopy (TEM), imaging flow cytometry (IFC), and nanoparticle tracking analysis (NTA). TEM images showed intact and roundish nanoparticles in pure samples. IFC analysis detected a prevalence of CD63+ EVs compared to CD9+, CD81+, and CD11c+ EVs. NTA confirmed the presence of small EVs with a concentration of similar to 10(10) EVs/mL that were comparable when stratifying the subjects by baseline demographics; conversely, concentration differed according to the health status across healthy donors and patients affected with autoimmune diseases (130 subjects in total, with 65 healthy donors and 65 idiopathic inflammatory myopathy (IIM) patients). Altogether, our data show that a combined EV isolation method, i.e., SEC followed by UF, is a reliable approach to isolate intact EVs with a significant yield from complex fluids, which might characterize disease conditions early.
There is still a need for an efficient method for the isolation of extracellular vesicles (EVs) from human blood that provides a reliable yield with acceptable purity. Blood is a source of circulating EVs, but soluble proteins and lipoproteins hamper their concentration, isolation, and detection. This study aims to investigate the efficiency of EV isolation and characterization methods not defined as “gold standard”. EVs were isolated from human platelet-free plasma (PFP) of patients and healthy donors through size-exclusion chromatography (SEC) combined with ultrafiltration (UF). Then, EVs were characterized using transmission electron microscopy (TEM), imaging flow cytometry (IFC), and nanoparticle tracking analysis (NTA). TEM images showed intact and roundish nanoparticles in pure samples. IFC analysis detected a prevalence of CD63+ EVs compared to CD9+, CD81+, and CD11c+ EVs. NTA confirmed the presence of small EVs with a concentration of ~10 10 EVs/mL that were comparable when stratifying the subjects by baseline demographics; conversely, concentration differed according to the health status across healthy donors and patients affected with autoimmune diseases (130 subjects in total, with 65 healthy donors and 65 idiopathic inflammatory myopathy (IIM) patients). Altogether, our data show that a combined EV isolation method, i.e., SEC followed by UF, is a reliable approach to isolate intact EVs with a significant yield from complex fluids, which might characterize disease conditions early.
Audience Academic
Author Bertazza, Loris
Gasparotto, Michela
Iaccarino, Luca
Zanatta, Elisabetta
Doria, Andrea
Franco, Chiara
Valadi, Hadi
Gatto, Mariele
Ghirardello, Anna
AuthorAffiliation 2 Unit of Endocrinology, Department of Medicine (DIMED), University of Padova, 35128 Padova, Italy
1 Unit of Rheumatology, Department of Medicine (DIMED), University of Padova, 35128 Padova, Italy
3 Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Guldhedsgatan 10A, 413 46 Gothenburg, Sweden
AuthorAffiliation_xml – name: 3 Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Guldhedsgatan 10A, 413 46 Gothenburg, Sweden
– name: 1 Unit of Rheumatology, Department of Medicine (DIMED), University of Padova, 35128 Padova, Italy
– name: 2 Unit of Endocrinology, Department of Medicine (DIMED), University of Padova, 35128 Padova, Italy
Author_xml – sequence: 1
  givenname: Chiara
  orcidid: 0000-0001-9027-511X
  surname: Franco
  fullname: Franco, Chiara
– sequence: 2
  givenname: Anna
  surname: Ghirardello
  fullname: Ghirardello, Anna
– sequence: 3
  givenname: Loris
  surname: Bertazza
  fullname: Bertazza, Loris
– sequence: 4
  givenname: Michela
  orcidid: 0000-0002-9930-2396
  surname: Gasparotto
  fullname: Gasparotto, Michela
– sequence: 5
  givenname: Elisabetta
  surname: Zanatta
  fullname: Zanatta, Elisabetta
– sequence: 6
  givenname: Luca
  surname: Iaccarino
  fullname: Iaccarino, Luca
– sequence: 7
  givenname: Hadi
  orcidid: 0000-0003-3482-2451
  surname: Valadi
  fullname: Valadi, Hadi
– sequence: 8
  givenname: Andrea
  orcidid: 0000-0003-0548-4983
  surname: Doria
  fullname: Doria, Andrea
– sequence: 9
  givenname: Mariele
  orcidid: 0000-0003-4012-1248
  surname: Gatto
  fullname: Gatto, Mariele
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36835073$$D View this record in MEDLINE/PubMed
https://gup.ub.gu.se/publication/325498$$DView record from Swedish Publication Index
BookMark eNptkk1v1DAQhi1URNuFG2dkiQsHUvyVrwtSuyxspUocSrlaTjLZ9cqxg53QLj-E34vDtrBbVZGSyPPMI834PUVH1llA6DUlZ5yX5IPedIEJIniW8WfohArGEkKy_Gjv_xidhrAhhHGWli_QMc8KnpKcn6Df1_oXJIu72oxBO4vna-86NbiVV_16i-euq7SFBt_qYY1vzOBVq6f3MMGLttW1BjuYLb4MzqgBAl7cxXINxoxGefwdgq5NPG6jFy_HTll8YZxr8LXq-qmgLV6CMlGvbIM_6QAqwEv0vFUmwKv77wzdfF58my-Tq69fLufnV0md0nxIgGWC0CalpBFV1XLCi1akVEBZ8LLhCniaqrICxtMqF0RleV5TWpOm4EArVvEZSnbecAv9WMne6075rXRKy9XYy3i0GmUAGRcnonSGPu74CHfQ1HF2r8xB22HF6rVcuZ-yLDPOeR4F7-4F3v0YIQyy02HalrLgxiBZXsQLYyynEX37CN240du4jkjlZSpYkbH_1EoZkNq2blr_JJXneUpLJjIuInX2BBWfBjpdx0DFW4XDhjf7g_6b8CE5EWA7oPYuBA-trPXwNxbRrI2kRE7xlPvxjE3vHzU9eJ_E_wAnz-iL
CitedBy_id crossref_primary_10_1002_advs_202401069
crossref_primary_10_1039_D3AY01704D
crossref_primary_10_1016_j_jddst_2024_106262
crossref_primary_10_3390_cells13242054
crossref_primary_10_1021_acsomega_3c07441
crossref_primary_10_3390_pharmaceutics16111394
crossref_primary_10_3390_biomedicines13020275
crossref_primary_10_1016_j_jaut_2024_103255
crossref_primary_10_1039_D3CP03129B
crossref_primary_10_1186_s12951_024_02298_7
crossref_primary_10_1016_j_bioactmat_2025_02_018
crossref_primary_10_1016_j_cej_2025_160234
crossref_primary_10_2217_nnm_2023_0344
crossref_primary_10_3390_ijms25116187
crossref_primary_10_1002_jex2_153
Cites_doi 10.3390/cells9091955
10.1080/20013078.2019.1688936
10.1038/s41598-021-91129-y
10.1080/20013078.2018.1560809
10.1002/jev2.12213
10.1038/s41598-017-15717-7
10.3390/ijms22158163
10.1080/20013078.2019.1587567
10.1002/jev2.12128
10.1056/NEJM197502132920706
10.1007/s00018-019-03071-y
10.1016/j.omtm.2020.07.012
10.1016/j.chroma.2020.461773
10.3390/biomedicines9020124
10.1097/BOR.0000000000000831
10.20944/preprints202007.0485.v2
10.1371/journal.pone.0204276
10.3389/fimmu.2021.566299
10.1016/j.bbcan.2018.11.006
10.3390/ijms22126417
10.1111/jth.12207
10.3389/fgene.2020.00700
10.1002/jev2.12145
10.1038/s42003-022-03569-5
10.1002/jev2.12143
10.1038/s41598-020-57497-7
10.1016/j.ymeth.2016.09.018
10.3390/cells8070727
10.1073/pnas.2107394119
10.1186/s12967-021-02775-9
10.3402/jev.v4.27369
10.1080/20013078.2018.1535750
10.1080/20013078.2018.1490145
10.1080/20013078.2018.1555419
10.3390/ijms21176097
10.1080/20013078.2018.1490143
10.1007/s00018-018-2806-z
10.1055/s-0038-1668544
10.3390/ijms21072514
10.3402/jev.v5.31242
10.1080/09537104.2020.1779924
10.1056/NEJM197502202920807
10.1371/journal.pone.0236439
10.7150/ijbs.39629
ContentType Journal Article
Copyright COPYRIGHT 2023 MDPI AG
2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023 by the authors. 2023
Copyright_xml – notice: COPYRIGHT 2023 MDPI AG
– notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023 by the authors. 2023
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
ADTPV
AOWAS
F1U
DOI 10.3390/ijms24043663
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database (subscription)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Göteborgs universitet
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Publicly Available Content Database


CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
Chemistry
EISSN 1422-0067
ExternalDocumentID oai_gup_ub_gu_se_325498
PMC9963337
A751924634
36835073
10_3390_ijms24043663
Genre Journal Article
GroupedDBID ---
29J
2WC
53G
5GY
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
8G5
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AFKRA
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1I
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
ESX
F5P
FRP
FYUFA
GNUQQ
GUQSH
GX1
HH5
HMCUK
HYE
IAO
IHR
ITC
KQ8
LK8
M1P
M2O
M48
MODMG
O5R
O5S
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RPM
TR2
TUS
UKHRP
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
3V.
7XB
8FK
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ADRAZ
ADTPV
AOWAS
C1A
F1U
IPNFZ
RIG
ID FETCH-LOGICAL-c517t-e26401d510d4bbf3038f4514e9839d3ae355a9be235b740a677c11c0d83e1b2b3
IEDL.DBID M48
ISSN 1422-0067
1661-6596
IngestDate Thu Aug 21 06:52:10 EDT 2025
Thu Aug 21 18:37:44 EDT 2025
Mon Jul 21 11:06:45 EDT 2025
Sat Aug 23 13:13:29 EDT 2025
Tue Jun 17 21:06:09 EDT 2025
Tue Jun 10 20:34:17 EDT 2025
Mon Jul 21 06:00:21 EDT 2025
Tue Jul 01 02:03:31 EDT 2025
Thu Apr 24 23:01:31 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords idiopathic inflammatory myopathies
extracellular vesicles
ultrafiltration
size-exclusion chromatography
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c517t-e26401d510d4bbf3038f4514e9839d3ae355a9be235b740a677c11c0d83e1b2b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-9027-511X
0000-0003-0548-4983
0000-0003-3482-2451
0000-0002-9930-2396
0000-0003-4012-1248
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ijms24043663
PMID 36835073
PQID 2779542862
PQPubID 2032341
ParticipantIDs swepub_primary_oai_gup_ub_gu_se_325498
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9963337
proquest_miscellaneous_2780062271
proquest_journals_2779542862
gale_infotracmisc_A751924634
gale_infotracacademiconefile_A751924634
pubmed_primary_36835073
crossref_citationtrail_10_3390_ijms24043663
crossref_primary_10_3390_ijms24043663
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20230211
PublicationDateYYYYMMDD 2023-02-11
PublicationDate_xml – month: 2
  year: 2023
  text: 20230211
  day: 11
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle International journal of molecular sciences
PublicationTitleAlternate Int J Mol Sci
PublicationYear 2023
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Gomes (ref_29) 2018; 118
Vogel (ref_35) 2016; 5
Allelein (ref_3) 2021; 11
ref_14
Rikkert (ref_34) 2021; 32
Karimi (ref_40) 2022; 11
Brennan (ref_42) 2020; 10
Veziroglu (ref_19) 2020; 11
ref_11
Woud (ref_30) 2022; 5
ref_32
ref_31
Bohan (ref_43) 1975; 292
Witwer (ref_5) 2018; 7
Tian (ref_4) 2020; 16
Berckmans (ref_33) 2019; 8
Gaspar (ref_26) 2020; 18
Benedikter (ref_20) 2018; 75
ref_38
Tkach (ref_25) 2022; 119
Guo (ref_18) 2021; 10
Takov (ref_17) 2019; 8
Lacroix (ref_45) 2013; 11
Yang (ref_27) 2021; 19
Lannigan (ref_39) 2017; 112
Bohan (ref_44) 1975; 292
Lu (ref_7) 2021; 12
Veerman (ref_2) 2021; 10
ref_24
Benedikter (ref_23) 2017; 7
Johnsen (ref_36) 2019; 1871
Donzelli (ref_41) 2021; 10
Foers (ref_16) 2018; 7
Bremer (ref_13) 2019; 8
ref_1
Bancu (ref_22) 2015; 4
Franco (ref_10) 2021; 33
Oeyen (ref_21) 2018; 7
ref_28
Rikkert (ref_37) 2019; 8
ref_9
Liangsupree (ref_12) 2021; 1636
Roura (ref_15) 2019; 76
ref_6
Zhao (ref_8) 2021; 2
References_xml – ident: ref_11
  doi: 10.3390/cells9091955
– volume: 8
  start-page: 1688936
  year: 2019
  ident: ref_33
  article-title: Extracellular vesicles and coagulation in blood from healthy humans revisited
  publication-title: J. Extracell. Vesicles
  doi: 10.1080/20013078.2019.1688936
– volume: 11
  start-page: 11585
  year: 2021
  ident: ref_3
  article-title: Potential and challenges of specifically isolating extracellular vesicles from heterogeneous populations
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-021-91129-y
– volume: 8
  start-page: 1560809
  year: 2019
  ident: ref_17
  article-title: Comparison of small extracellular vesicles isolated from plasma by ultracentrifugation or size-exclusion chromatography: Yield, purity and functional potential
  publication-title: J. Extracell. Vesicles
  doi: 10.1080/20013078.2018.1560809
– volume: 11
  start-page: e12213
  year: 2022
  ident: ref_40
  article-title: Tetraspanins distinguish separate extracellular vesicle subpopulations in human serum and plasma—Contributions of platelet extracellular vesicles in plasma samples
  publication-title: J. Extracell. Vesicles
  doi: 10.1002/jev2.12213
– volume: 7
  start-page: 15297
  year: 2017
  ident: ref_23
  article-title: Ultrafiltration combined with size exclusion chromatography efficiently isolates extracellular vesicles from cell culture media for compositional and functional studies
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-15717-7
– ident: ref_9
  doi: 10.3390/ijms22158163
– volume: 8
  start-page: 1587567
  year: 2019
  ident: ref_13
  article-title: Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material
  publication-title: J. Extracell. Vesicles
  doi: 10.1080/20013078.2019.1587567
– volume: 10
  start-page: e12128
  year: 2021
  ident: ref_2
  article-title: Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin
  publication-title: J. Extracell. Vesicles
  doi: 10.1002/jev2.12128
– volume: 292
  start-page: 344
  year: 1975
  ident: ref_43
  article-title: Polymyositis and dermatomyositis (First of Two Parts)
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM197502132920706
– volume: 76
  start-page: 2369
  year: 2019
  ident: ref_15
  article-title: Extracellular vesicle isolation methods: Rising impact of size-exclusion chromatography
  publication-title: Cell. Mol. Life Sci.
  doi: 10.1007/s00018-019-03071-y
– volume: 18
  start-page: 723
  year: 2020
  ident: ref_26
  article-title: Simple and Fast SEC-Based Protocol to Isolate Human Plasma-Derived Extracellular Vesicles for Transcriptional Research
  publication-title: Mol. Ther. Methods Clin. Dev.
  doi: 10.1016/j.omtm.2020.07.012
– volume: 1636
  start-page: 461773
  year: 2021
  ident: ref_12
  article-title: Modern isolation and separation techniques for extracellular vesicles
  publication-title: J. Chromatogr. A
  doi: 10.1016/j.chroma.2020.461773
– ident: ref_38
  doi: 10.3390/biomedicines9020124
– volume: 33
  start-page: 522
  year: 2021
  ident: ref_10
  article-title: Lymphocyte immunophenotyping in inflammatory myositis: A review
  publication-title: Curr. Opin. Rheumatol.
  doi: 10.1097/BOR.0000000000000831
– ident: ref_14
  doi: 10.20944/preprints202007.0485.v2
– ident: ref_24
  doi: 10.1371/journal.pone.0204276
– volume: 12
  start-page: 566299
  year: 2021
  ident: ref_7
  article-title: The Role of Extracellular Vesicles in the Pathogenesis and Treatment of Autoimmune Disorders
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2021.566299
– volume: 1871
  start-page: 109
  year: 2019
  ident: ref_36
  article-title: What is the blood concentration of extracellular vesicles? Implications for the use of extracellular vesicles as blood-borne biomarkers of cancer
  publication-title: Biochim. Biophys. Acta Rev. Cancer
  doi: 10.1016/j.bbcan.2018.11.006
– ident: ref_1
  doi: 10.3390/ijms22126417
– volume: 11
  start-page: 1190
  year: 2013
  ident: ref_45
  article-title: Standardization of pre-analytical variables in plasma microparticle determination: Results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop
  publication-title: J. Thromb. Haemost.
  doi: 10.1111/jth.12207
– volume: 2
  start-page: 80
  year: 2021
  ident: ref_8
  article-title: Isolation and analysis methods of extracellular vesicles (EVs)
  publication-title: Extracell. Vesicles Circ. Nucleic Acids
– volume: 11
  start-page: 700
  year: 2020
  ident: ref_19
  article-title: Characterizing Extracellular Vesicles and Their Diverse RNA Contents
  publication-title: Front. Genet.
  doi: 10.3389/fgene.2020.00700
– volume: 10
  start-page: e12145
  year: 2021
  ident: ref_18
  article-title: Establishment of a simplified dichotomic size-exclusion chromatography for isolating extracellular vesicles toward clinical applications
  publication-title: J. Extracell. Vesicles
  doi: 10.1002/jev2.12145
– volume: 5
  start-page: 633
  year: 2022
  ident: ref_30
  article-title: An imaging flow cytometry-based methodology for the analysis of single extracellular vesicles in unprocessed human plasma
  publication-title: Commun. Biol.
  doi: 10.1038/s42003-022-03569-5
– volume: 10
  start-page: 12143
  year: 2021
  ident: ref_41
  article-title: Small extracellular vesicle-derived miR-574-5p regulates PGE2-biosynthesis via TLR7/8 in lung cancer
  publication-title: J. Extracell. Vesicles
  doi: 10.1002/jev2.12143
– volume: 10
  start-page: 1039
  year: 2020
  ident: ref_42
  article-title: A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-57497-7
– volume: 112
  start-page: 55
  year: 2017
  ident: ref_39
  article-title: Imaging flow cytometry for the characterization of extracellular vesicles
  publication-title: Methods
  doi: 10.1016/j.ymeth.2016.09.018
– ident: ref_32
  doi: 10.3390/cells8070727
– volume: 119
  start-page: e2107394119
  year: 2022
  ident: ref_25
  article-title: Extracellular vesicles from triple negative breast cancer promote pro-inflammatory macrophages associated with better clinical outcome
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.2107394119
– volume: 19
  start-page: 104
  year: 2021
  ident: ref_27
  article-title: Extracellular vesicles isolated by size-exclusion chromatography present suitability for RNomics analysis in plasma
  publication-title: J. Transl. Med.
  doi: 10.1186/s12967-021-02775-9
– volume: 4
  start-page: 27369
  year: 2015
  ident: ref_22
  article-title: Size-exclusion chromatography-based enrichment of extracellular vesicles from urine samples
  publication-title: J. Extracell. Vesicles
  doi: 10.3402/jev.v4.27369
– volume: 7
  start-page: 1535750
  year: 2018
  ident: ref_5
  article-title: Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
  publication-title: J. Extracell. Vesicles
  doi: 10.1080/20013078.2018.1535750
– volume: 7
  start-page: 1490145
  year: 2018
  ident: ref_16
  article-title: Enrichment of extracellular vesicles from human synovial fluid using size exclusion chromatography
  publication-title: J. Extracell. Vesicles
  doi: 10.1080/20013078.2018.1490145
– volume: 8
  start-page: 1555419
  year: 2019
  ident: ref_37
  article-title: Quality of extracellular vesicle images by transmission electron microscopy is operator and protocol dependent
  publication-title: J. Extracell. Vesicles
  doi: 10.1080/20013078.2018.1555419
– ident: ref_6
  doi: 10.3390/ijms21176097
– volume: 7
  start-page: 1490143
  year: 2018
  ident: ref_21
  article-title: Ultrafiltration and size exclusion chromatography combined with asymmetrical-flow field-flow fractionation for the isolation and characterisation of extracellular vesicles from urine
  publication-title: J. Extracell. Vesicles
  doi: 10.1080/20013078.2018.1490143
– volume: 75
  start-page: 2321
  year: 2018
  ident: ref_20
  article-title: Redox-dependent thiol modifications: Implications for the release of extracellular vesicles
  publication-title: Cell. Mol. Life Sci.
  doi: 10.1007/s00018-018-2806-z
– volume: 118
  start-page: 1612
  year: 2018
  ident: ref_29
  article-title: Analytical Considerations in Nanoscale Flow Cytometry of Extracellular Vesicles to Achieve Data Linearity
  publication-title: Thromb. Haemost.
  doi: 10.1055/s-0038-1668544
– ident: ref_31
  doi: 10.3390/ijms21072514
– volume: 5
  start-page: 31242
  year: 2016
  ident: ref_35
  article-title: A standardized method to determine the concentration of extracellular vesicles using tunable resistive pulse sensing
  publication-title: J. Extracell. Vesicles
  doi: 10.3402/jev.v5.31242
– volume: 32
  start-page: 440
  year: 2021
  ident: ref_34
  article-title: Platelet removal by single-step centrifugation
  publication-title: Platelets
  doi: 10.1080/09537104.2020.1779924
– volume: 292
  start-page: 403
  year: 1975
  ident: ref_44
  article-title: Polymyositis and dermatomyositis (Second of Two Parts)
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM197502202920807
– ident: ref_28
  doi: 10.1371/journal.pone.0236439
– volume: 16
  start-page: 620
  year: 2020
  ident: ref_4
  article-title: Potential roles of extracellular vesicles in the pathophysiology, diagnosis, and treatment of autoimmune diseases
  publication-title: Int. J. Biol. Sci.
  doi: 10.7150/ijbs.39629
SSID ssj0023259
Score 2.470214
Snippet There is still a need for an efficient method for the isolation of extracellular vesicles (EVs) from human blood that provides a reliable yield with acceptable...
SourceID swepub
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 3663
SubjectTerms Autoimmune diseases
Biochemistry & Molecular Biology
Biomarkers
Blood
Cell culture
Chemistry
Chromatography
Chromatography, Gel - methods
Disease
Ethylenediaminetetraacetic acid
Extracellular vesicles
Extracellular Vesicles - chemistry
Flow cytometry
Humans
idiopathic inflammatory myopathies
Lipoproteins - metabolism
Membrane lipids
Microscopy, Electron, Transmission
Molecular Biology
Molekylärbiologi
Morphology
Nanoparticles
Plasma
polymyositis
Proteins
size-exclusion chromatography
ultrafiltration
Ultrafiltration - methods
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagFRIXxJtAQUbicUBR13FiJyfUQqqCRIUoi3qzEntSgkJ2IRup5Yfwe5lJvEtTCa5rR7F2Xt9Mxt8w9iyrMqcAilA4TFFiiFRYOmtDC5WypUTQO5QGPhypw3n8_iQ58QW3zrdVrn3i4KjdwlKNfDfSOksQK6vo9fJHSFOj6OuqH6FxlW2jC05Rw7f386OPnzYpl4yGcWkCo1CokkyNre8SE_3d-tv3LiJuGaXkJChdds0XYtPlvskJu-gQkQ5ushseSvK9Ufa32BVob7Nr43DJ8zvs93H9C8L8zDY9VcQ40eAiPPUU1RwdASbF4DhVYvm8wVdVdeNJdHk-MEvgAZpz_g7VkxApz89wmSr91LrKv0A3tNRxuqHCh48BfJ_a4PlxQZTDHa9bPt5y4kXr-NvxU9BdNj_IP785DP0UhtAmQq9CFB_mYA5t18VlWWHIS6sYYRZkiK2cLAARS5GVEMmk1PGsUFpbIezMpRJEGZXyHttqFy08YHwGLpOpc0UlUwyekGqbxgVCRitSsBoC9motBmM9RTlNymgMpiokNHNRaAF7vtm9HKk5_rHvJUnUkMXS31T4iwd4JuK-Mns6oSxUyThgO5OdaGl2urzWCeMtvTN_9TJgTzfL9CR1r7Ww6GlPSndVIy0Cdn9Uoc2JpUIMjH42YHqiXJsNxP89XWnrrwMPOKaqUkodsBejGk4eOe2XBn867U0HRlIZIH34__M_YtcjtBhqSRdih22tfvbwGBHXqnzizeoPeVMvkA
  priority: 102
  providerName: ProQuest
Title Size-Exclusion Chromatography Combined with Ultrafiltration Efficiently Isolates Extracellular Vesicles from Human Blood Samples in Health and Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/36835073
https://www.proquest.com/docview/2779542862
https://www.proquest.com/docview/2780062271
https://pubmed.ncbi.nlm.nih.gov/PMC9963337
https://gup.ub.gu.se/publication/325498
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb9QwEB71IVAviDeBsjISjwMKbOIkdg4ItZClILVClEV7ixLbKUEhLc1G2uWH8HuZyUtNoZc9rMeKFc9kvhmPvwF4GmahDoxJbEdjiOIZN7BTrZStTBaolCPobVIDh0fBwdz7tPAXG9B3G-1eYPXf0I76Sc3Pi1erX-u3aPBvKOLEkP11_uNn5RJLDHrPTdhGnySoicOhN5wnIGzww7bs_Z8ZO3CdB4hDpoKPfNPlL_QFF3W5fHJEMto4ptlNuNEhSrbXqsAt2DDlbbjW9phc34E_x_lvY0crVdSUGGPEhosotWOqZvg9wNjYaEYJWTYv8FFZXnRcuixqCCZwAcWafUQtJWDKohUOU8KfKljZN1M1lXWMLqqw5kyA7VM1PDtOiHm4YnnJ2stOLCk1e9-eCN2F-Sz6-u7A7pox2Mp3xNLGXcRQTKMJay9NM_R8MvMQbZkQIZbmiUHgkoSpcbmfCm-aBEIox1FTLblxUjfl92CrPC3NA2BTo0MutU4yLtGHGimU9BJEjsqRRgljwct-G2LVMZVTw4wixoiF9i--uH8WPBukz1qGjivkXtCOxqRK9JqS7v4BrokosOI94VMwGnDPgt2RJBqcGg_3OhH3-hq7QoQ-hnKBa8GTYZhmUhFbaU5rkpF0ZdUVjgX3WxUaVtyroAVipFyDANGAj0fK_HtDB44RK-dcWPC8VcPRlJP6LMa_Tuq4MjGnbIB8eOXDH8GOi7ZCRemOswtby_PaPEbMtUwnsCkWAn_l7MMEtvejo89fJuQF_UljaH8BXyEzBA
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIgQXxBtDgUWicEBW41171z4gVGiqhD4ubVBuW3t3XYKCE3AiGn4IP4PfyIztpHUluPXqHcejzHt39huAV0meWOlc6gcWS5TQceln1hjfuFyaTGDSW20NHBzK3iD8NIyGa_BneReG2iqXPrFy1HZiaI98iyuVRJgrS_5--t2nqVF0urocoVGrxZ5b_MSSrXzX30H5bnK-2z3-2PObqQK-iQI185EdrCks6qINsyxHFx7nIaYNLsFcwYrUYQROk8xxEWUq7KRSKRMEpmNj4YKMZwJ_9xpcx8DboRZCNTwv8ASvhrMFGPN8GSWybrQXIulsjb5-Kzkh2UgpWiHwciC4EAkvd2m2sEyr-Ld7B243iSvbrjXtLqy54h7cqEdZLu7D76PRL-d3z8x4TvtvjEB3MRluALEZuh0swZ1ltO_LBmP8VD4aN5C9rFvhWCAD4wXrozFQ_su6Z7hM5wrUKMs-u7Jq4GN0H4ZVRw_sAzXds6OUAI5LNipYfaeKpYVlO_XB0wMYXIl0HsJ6MSncY2AdZxMRW5vmIsZQ7WJl4jDFBNUEsTPKefB2KQZtGkB0mssx1lgYkdD0RaF5sLmintZAIP-ge0MS1eQf6G9Km2sOyBMhbeltFVHNK0XowUaLEu3atJeXOqEbv1Lqcyvw4OVqmd6kXrnCTeZEE9PNWK4CDx7VKrTiWEjMuNGre6BayrUiILTx9kox-lKhjmNhLIRQHryu1bD1yul8qvHR6VyXTgvadIif_J__F3Czd3ywr_f7h3tP4RZH66Fm-CDYgPXZj7l7hrneLHteGRiDk6u26L_kv2nd
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwED-NIRAviP8EBhiJwQOK2tiJnTwgNGirlcGENIb65iW2M4pKWkgrVj4IH4ZPx12SdsskeNtrfGlOvf_2-XcAz5I8sdK51A8sliih49LPrDG-cbk0mcCkt9oa-LAvdw_Dd6NotAF_VndhqK1y5RMrR22nhvbIO1ypJMJcWfJO3rRFfOwNXs---zRBik5aV-M0ahXZc8ufWL6Vr4Y9lPU254P-p7e7fjNhwDdRoOY-sob1hUW9tGGW5ejO4zzEFMIlmDdYkTqMxmmSOS6iTIXdVCplgsB0bSxckPFM4O9egstKYNhEW1Kj02JP8GpQW4Dxz5dRIuumeyGSbmf89VvJCdVGStEKh-eDwpmoeL5js4VrWsXCwQ243iSxbKfWupuw4YpbcKUea7m8Db8Pxr-c3z8xkwXtxTEC4MXEuAHHZuiCsBx3ltEeMDuc4Kfy8aSB72X9CtMCGZgs2RANg3Jh1j_BZTpjoKZZ9tmVVTMfo7sxrDqGYG-oAZ8dpAR2XLJxwer7VSwtLOvVh1B34PBCpHMXNotp4e4D6zqbiNjaNBcxhm0XKxOHKSarJoidUc6DlysxaNOAo9OMjonGIomEps8KzYPtNfWsBgX5B90LkqgmX0F_U9pceUCeCHVL76iI6l8pQg-2WpRo46a9vNIJ3fiYUp9ahAdP18v0JvXNFW66IJqYbslyFXhwr1ahNcdCYvaNHt4D1VKuNQEhj7dXivGXCoEci2QhhPLgea2GrVeOFzONj44XunRa0AZE_OD__D-Bq2jL-v1wf-8hXONoPNQXHwRbsDn_sXCPMO2bZ48r-2JwdNEG_RepGW4T
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Size-Exclusion+Chromatography+Combined+with+Ultrafiltration+Efficiently+Isolates+Extracellular+Vesicles+from+Human+Blood+Samples+in+Health+and+Disease&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Franco%2C+Chiara&rft.au=Ghirardello%2C+Anna&rft.au=Bertazza%2C+Loris&rft.au=Gasparotto%2C+Michela&rft.date=2023-02-11&rft.eissn=1422-0067&rft.volume=24&rft.issue=4&rft_id=info:doi/10.3390%2Fijms24043663&rft_id=info%3Apmid%2F36835073&rft.externalDocID=36835073
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon